| 1. | Pal, E, T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, T. Yamamura: Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 natural killer (NK) T cells. J Immunol 166: 662-668, 2001 |
| 2. | Takahashi, K, S. Miyake, T. Kondo, K. Terao, M. Hatakenaka, S. Hashimoto and T. Yamamura : Natural killer type 2 (NK2) bias in remission of multiple sclerosis. J Clin Invest 107:R23-R29, 2001 |
| 3. | Miyamoto, K, S. Miyake, and T. Yamamura: A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531-534, 2001 |
| 4. | Maeda, M, S. Lohwasser, T. Yamamura, and F. Takei: Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J Immunol 167: 4180-4186, 2001 |
| 5. | Miyamoto, K, N. Oka, T. Kawasaki, S. Miyake, T. Yamamura, and I. Akiguchi: new cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve 25：280-282, 2002 |
| 6. | Gumperz, J.E, S. Miyake, T. Yamamura, and M.B. Brenner: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195: 625-636, 2002 |
| 7. | Kondo, T, K. Takahashi, N. Kohara, Y. Takahashi, S. Hayashi, H. Takahashi, H. Matsuo, M. Yamazaki, K. Inoue, K. Miyamoto, and T. Yamamura: Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): Three genetic forms. Neurology 59: 1105-1107, 2002 |
| 8. | Araki, M, T. Kondo, J.E. Gumperz, M.B. Brenner, S. Miyake and T. Yamamura: Th2 bias of CD4+ NKT cells derived form multiple sclerosis in remission. Int Immunol 15: 279-288, 2003 |
| 9. | Sakami, S, A. Nakata, T. Yamamura, and N. Kawamura: Stressors increase in vitro T cell apoptosis in humans. Neuroimmunomodulation 10:224-231 (2002-2003) |
| 10. | Miyamoto, K, S. Miyake, M. Schachner, and T. Yamamura: Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide. Eur J Immunol 33: 656-665, 2003 |
| 11. | Watabe, K, T. Sakamoto, Y. Kawazoe, M. Michikawa, K. Miyamoto, T. Yamamura, H. Saya and N. Araki. Tissue culture methods to study neurological disorders: Establishment of immortalized Schwann cells from murine disease models. Neuropathology 23:68-78, 2003 |
| 12. | Koike, F, J-i. Satoh, T. Kondo, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa, and T. Yamamura: Microarray analysis identifies IFNβ-regulated genes in multiple sclerosis. J Neuroimunol 139: 109-118, 2003 |
| 13. | Nakamura, T, K.-H. Sonoda, D.E. Faunce, J. Gumperz, T. Yamamura., S. Miyake, J. Stein-Streilein: CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 171:1266-1271, 2003 |
| 14. | Bedoui, S, N. Kawamura, R.H. Straub, R. Pabst, T. Yamamura, and S. von Horsten: Review. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134: 1-11, 2003 |
| 15. | Bedoui, S, S. Miyake, Y. Lin, K. Miyamoto, S. Oki, N. Kawamura, A. Beck-Sickinger, S. von Hoersten, and T. Yamamura: Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY Y1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 171: 3451-3458, 2003 |
| 16. | Stanic, A.K, R. Shashidharamurthy, J.S. Bezradica, N. Matsuki, Y. Yoshimura, S. Miyake, E.Y. Choi, T.D. Schell, L. Van Kaer, S.S. Tevethia, D.C. Roopenian, T. Yamamura and S. Joyce: Another view of T cell antigen recoginition: Co-operative engagement of glycolipid antigens by Vα14Jα18 natural TCR. J Immunol 171:4539-4551, 2003 |